Further investigations revealed that pre-TACE STIP1 levels showed no significant difference between responsive and non-responsive patients (P = 0.669), whereas post-TACE STIP1 levels were significantly decreased in responsive HCC patients (P < 0.001; Figure 5B). The gene discussed is STIP1; the disease is hepatocellular carcinoma.